Total Payments
$89,085
2024 Payments
$36,043
Companies
10
Transactions
53
Medicare Patients
327
Medicare Billing
$117,705
Payment Breakdown by Category
Consulting$58,052 (65.2%)
Other$23,245 (26.1%)
Travel$5,768 (6.5%)
Food & Beverage$1,281 (1.4%)
Research$739.39 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,052 | 17 | 65.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,378 | 1 | 16.1% |
| Honoraria | $8,867 | 2 | 10.0% |
| Travel and Lodging | $5,768 | 15 | 6.5% |
| Food and Beverage | $1,281 | 16 | 1.4% |
| Unspecified | $739.39 | 2 | 0.8% |
Payments by Type
General
$88,346
51 transactions
Research
$739.39
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Co., Ltd. | $22,000 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $16,201 | 5 | $0 (2024) |
| CSL Behring | $13,794 | 6 | $0 (2022) |
| GENZYME CORPORATION | $11,807 | 10 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $10,500 | 1 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $7,968 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $3,376 | 2 | $0 (2024) |
| PFIZER INC. | $1,750 | 1 | $0 (2024) |
| One Lambda, Inc. | $1,523 | 2 | $0 (2024) |
| OrganOx Ltd | $166.80 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,043 | 14 | SANOFI-AVENTIS U.S. LLC ($16,201) |
| 2023 | $789.67 | 2 | One Lambda, Inc. ($622.87) |
| 2022 | $26,611 | 11 | Otsuka Pharmaceutical Co., Ltd. ($21,800) |
| 2021 | $1,270 | 1 | Regeneron Pharmaceuticals, Inc. ($1,270) |
| 2020 | $1,905 | 1 | Regeneron Pharmaceuticals, Inc. ($1,905) |
| 2019 | $22,467 | 24 | GENZYME CORPORATION ($11,807) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka Pharmaceutical Co., Ltd. | — | Food and Beverage | In-kind items and services | $150.29 | General |
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,558.00 | General |
| 10/17/2024 | One Lambda, Inc. | — | Honoraria | Cash or cash equivalent | $900.00 | General |
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,378.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $742.96 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $449.22 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $320.88 | General |
| Category: Oncology | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $309.47 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,558.00 | General |
| 06/18/2024 | Otsuka Pharmaceutical Co., Ltd. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 06/12/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,350.00 | General |
| 06/01/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.87 | General |
| 05/22/2024 | Mallinckrodt Hospital Products Inc. | UVADEX (Drug) | Consulting Fee | Cash or cash equivalent | $10,500.00 | General |
| Category: CRITICAL CARE | ||||||
| 04/23/2024 | PFIZER INC. | ATGAM (Biological) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: HEMATOLOGY | ||||||
| 11/06/2023 | One Lambda, Inc. | — | Travel and Lodging | Cash or cash equivalent | $622.87 | General |
| 06/04/2023 | OrganOx Ltd | METRA (Device) | Food and Beverage | Cash or cash equivalent | $166.80 | General |
| Category: TRANSPLANT SURGERY | ||||||
| 11/03/2022 | Regeneron Pharmaceuticals, Inc. | — | — | In-kind items and services | $451.48 | Research |
| Study: REGN5458 Clinical Development Program | ||||||
| 09/27/2022 | Otsuka Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| 09/27/2022 | Otsuka Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| 08/18/2022 | Otsuka Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 08/18/2022 | Otsuka Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 08/12/2022 | Regeneron Pharmaceuticals, Inc. | — | — | In-kind items and services | $287.91 | Research |
| Study: REGN5458 Clinical Development Program | ||||||
| 05/26/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $4,071.25 | General |
| 04/27/2022 | Otsuka Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 04/27/2022 | Otsuka Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| REGN5458 Clinical Development Program | Regeneron Pharmaceuticals, Inc. | $739.39 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 17 | $4,624 | $1,436 |
| 2022 | 6 | 90 | 105 | $395,988 | $37,714 |
| 2021 | 6 | 101 | 117 | $394,693 | $39,102 |
| 2020 | 7 | 121 | 135 | $394,606 | $39,453 |
Total Patients
327
Total Services
374
Medicare Billing
$117,705
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 17 | $4,624 | $1,436 | 31.0% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 20 | 20 | $351,348 | $30,457 | 8.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 16 | $7,776 | $2,432 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 21 | $5,355 | $1,568 | 29.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 17 | $4,250 | $1,339 | 31.5% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 19 | 19 | $23,995 | $1,033 | 4.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 12 | $3,264 | $885.41 | 27.1% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 18 | 18 | $347,529 | $31,324 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 28 | $7,140 | $2,107 | 29.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 24 | 26 | $7,072 | $2,061 | 29.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $5,346 | $1,556 | 29.1% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2021 | 18 | 18 | $24,822 | $1,160 | 4.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 16 | $2,784 | $893.76 | 32.1% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 18 | 18 | $343,710 | $31,291 | 9.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 24 | 24 | $6,528 | $1,926 | 29.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 25 | $4,350 | $1,409 | 32.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $4,592 | $1,399 | 30.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 13 | 16 | $5,504 | $1,304 | 23.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 16 | 20 | $5,100 | $1,134 | 22.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2020 | 18 | 18 | $24,822 | $990.00 | 4.0% |
About Dr. Stuart Knechtle, MD
Dr. Stuart Knechtle, MD is a Transplant Surgery healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013971670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Knechtle, MD has received a total of $89,085 in payments from pharmaceutical and medical device companies, with $36,043 received in 2024. These payments were reported across 53 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($58,052).
As a Medicare-enrolled provider, Knechtle has provided services to 327 Medicare beneficiaries, totaling 374 services with total Medicare billing of $117,705. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Transplant Surgery
- Other Specialties Transplant Surgery
- Location Atlanta, GA
- Active Since 04/12/2006
- Last Updated 11/19/2014
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1013971670
Products in Payments
- REZUROCK (Drug) $16,201
- THYMOGLOBULIN (Drug) $11,807
- UVADEX (Drug) $10,500
- ATGAM (Biological) $1,750
- METRA (Device) $166.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in Atlanta
Dr. Roshan Shrestha, Md, MD
Transplant Surgery — Payments: $477,841
Transplant Surgery $477,841
Dr. Nicole Turgeon, M.d, M.D
Transplant Surgery — Payments: $89,786
Transplant Surgery $89,786
Allan Kirk, Md, MD
Transplant Surgery — Payments: $66,628
Transplant Surgery $66,628
Andrew Adams, Md, Phd, MD, PHD
Transplant Surgery — Payments: $63,762
Transplant Surgery $63,762
Marty Sellers, Md Mph, MD MPH
Transplant Surgery — Payments: $49,106
Transplant Surgery $49,106
Evan Weitman, Md, MD
Transplant Surgery — Payments: $34,033
Transplant Surgery $34,033